Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Adaptation of the Drug and Drug Problems Perception Questionnaire to assess healthcare provider attitudes toward adolescent substance use.

Connors E, McKenzie M, Robinson P, Tager M, Scardamalia K, Oros M, Hoover S.

Prev Med Rep. 2019 Mar 16;14:100852. doi: 10.1016/j.pmedr.2019.100852. eCollection 2019 Jun.

2.

Nuclear accumulation of SHIP1 mutants derived from AML patients leads to increased proliferation of leukemic cells.

Nalaskowski MM, Ehm P, Rehbach C, Nelson N, Täger M, Modest K, Jücker M.

Cell Signal. 2018 Sep;49:87-94. doi: 10.1016/j.cellsig.2018.05.006. Epub 2018 May 28.

PMID:
29852247
3.

SHIP1, but not an AML-derived SHIP1 mutant, suppresses myeloid leukemia growth in a xenotransplantation mouse model.

Täger M, Horn S, Latuske E, Ehm P, Schaks M, Nalaskowski M, Fehse B, Fiedler W, Stocking C, Wellbrock J, Jücker M.

Gene Ther. 2017 Nov;24(11):749-753. doi: 10.1038/gt.2017.88. Epub 2017 Nov 16.

PMID:
29143813
4.

Preclinical pilot study monitoring topical drug penetration and dermal bioavailability of a peptidase inhibitor from different galenic formulations into pig dermis, using cutaneous microdialysis.

Quist SR, Heimburg A, Bank U, Mahnkopf D, Koch G, Gollnick H, Täger M, Ansorge S.

Clin Exp Dermatol. 2017 Aug;42(6):607-613. doi: 10.1111/ced.13105. Epub 2017 May 29.

PMID:
28556026
5.

[Etiology and antimicrobial resistance profile of urinary tract infection in children, Valdivia 2012].

Herrera C, Navarro D, Täger M.

Rev Chilena Infectol. 2014 Dec;31(6):757-8. doi: 10.4067/S0716-10182014000600019. Spanish.

6.

Dipeptidyl peptidase IV, aminopeptidase N and DPIV/APN-like proteases in cerebral ischemia.

Röhnert P, Schmidt W, Emmerlich P, Goihl A, Wrenger S, Bank U, Nordhoff K, Täger M, Ansorge S, Reinhold D, Striggow F.

J Neuroinflammation. 2012 Feb 28;9:44. doi: 10.1186/1742-2094-9-44.

7.

Insufficient endogenous redox buffer capacity may underlie neuronal vulnerability to cerebral ischemia and reperfusion.

Röhnert P, Schröder UH, Ziabreva I, Täger M, Reymann KG, Striggow F.

J Neurosci Res. 2012 Jan;90(1):193-202. doi: 10.1002/jnr.22754. Epub 2011 Oct 4.

PMID:
21971686
8.

Divergent actions by inhibitors of DP IV and APN family enzymes on CD4+ Teff cell motility and functions.

Biton A, Ansorge S, Bank U, Täger M, Reinhold D, Brocke S.

Immunobiology. 2011 Dec;216(12):1295-301. doi: 10.1016/j.imbio.2011.07.001. Epub 2011 Jul 7.

PMID:
21802166
9.

RGB marking facilitates multicolor clonal cell tracking.

Weber K, Thomaschewski M, Warlich M, Volz T, Cornils K, Niebuhr B, Täger M, Lütgehetmann M, Pollok JM, Stocking C, Dandri M, Benten D, Fehse B.

Nat Med. 2011 Apr;17(4):504-9. doi: 10.1038/nm.2338. Epub 2011 Mar 27.

PMID:
21441917
10.

Outside or inside: role of the subcellular localization of DP4-like enzymes for substrate conversion and inhibitor effects.

Bank U, Heimburg A, Wohlfarth A, Koch G, Nordhoff K, Julius H, Helmuth M, Breyer D, Reinhold D, Täger M, Ansorge S.

Biol Chem. 2011 Mar;392(3):169-87. doi: 10.1515/BC.2011.025.

PMID:
21194378
11.

PETIR-001, a dual inhibitor of dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN), ameliorates experimental autoimmune encephalomyelitis in SJL/J mice.

Reinhold D, Bank U, Entz D, Goihl A, Stoye D, Wrenger S, Brocke S, Thielitz A, Stefin S, Nordhoff K, Heimburg A, Täger M, Ansorge S.

Biol Chem. 2011 Mar;392(3):233-7. doi: 10.1515/BC.2011.024.

PMID:
21194377
12.

Novel aspects of cellular action of dipeptidyl peptidase IV/CD26.

Ansorge S, Nordhoff K, Bank U, Heimburg A, Julius H, Breyer D, Thielitz A, Reinhold D, Täger M.

Biol Chem. 2011 Mar;392(3):153-68. doi: 10.1515/BC.2011.008.

PMID:
21194362
13.

Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.

Reinhold D, Goihl A, Wrenger S, Reinhold A, Kühlmann UC, Faust J, Neubert K, Thielitz A, Brocke S, Täger M, Ansorge S, Bank U.

Clin Chem Lab Med. 2009;47(3):268-74.

PMID:
19676138
14.

Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functions.

Ansorge S, Bank U, Heimburg A, Helmuth M, Koch G, Tadje J, Lendeckel U, Wolke C, Neubert K, Faust J, Fuchs P, Reinhold D, Thielitz A, Täger M.

Clin Chem Lab Med. 2009;47(3):253-61. doi: 10.1515/CCLM.2009.063. Review.

PMID:
19327105
15.

Inflammatory bowel diseases: multiple benefits from therapy with dipeptidyl- and alanyl-aminopeptidase inhibitors.

Bank U, Bohr UR, Reinhold D, Lendeckel U, Ansorge S, Malfertheiner P, Tager M.

Front Biosci. 2008 May 1;13:3699-713. Review.

PMID:
18508466
16.

Effect of telmisartan on nitric oxide--asymmetrical dimethylarginine system: role of angiotensin II type 1 receptor gamma and peroxisome proliferator activated receptor gamma signaling during endothelial aging.

Scalera F, Martens-Lobenhoffer J, Bukowska A, Lendeckel U, Täger M, Bode-Böger SM.

Hypertension. 2008 Mar;51(3):696-703. doi: 10.1161/HYPERTENSIONAHA.107.104570. Epub 2008 Feb 4.

PMID:
18250362
17.

The ectopeptidases dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related enzymes as possible targets in the treatment of skin diseases.

Thielitz A, Ansorge S, Bank U, Tager M, Wrenger S, Gollnick H, Reinhold D.

Front Biosci. 2008 Jan 1;13:2364-75. Review.

PMID:
17981718
18.

DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis.

Reinhold D, Bank U, Täger M, Ansorge S, Wrenger S, Thielitz A, Lendeckel U, Faust J, Neubert K, Brocke S.

Front Biosci. 2008 Jan 1;13:2356-63. Review.

PMID:
17981717
19.

Gatekeeper function of the RUNX1 transcription factor in acute leukemia.

Niebuhr B, Fischer M, Täger M, Cammenga J, Stocking C.

Blood Cells Mol Dis. 2008 Mar-Apr;40(2):211-8. Epub 2007 Oct 24. Review.

PMID:
17920312
20.

Dual inhibition of dipeptidyl peptidase IV and aminopeptidase N suppresses inflammatory immune responses.

Reinhold D, Biton A, Goihl A, Pieper S, Lendeckel U, Faust J, Neubert K, Bank U, Täger M, Ansorge S, Brocke S.

Ann N Y Acad Sci. 2007 Sep;1110:402-9. Review.

PMID:
17911455
21.

Inhibition of alanyl-aminopeptidase on CD4+CD25+ regulatory T-cells enhances expression of FoxP3 and TGF-beta1 and ameliorates acute colitis in mice.

Bank U, Tadje J, Täger M, Wolke C, Bukowska A, Ittenson A, Reinhold D, Helmuth M, Ansorge S, Shakespeare A, Vieth M, Malfertheiner P, Naumann M, Lendeckel U.

Int J Mol Med. 2007 Oct;20(4):483-92.

PMID:
17786278
22.

Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.

Reinhold D, Biton A, Pieper S, Lendeckel U, Faust J, Neubert K, Bank U, Täger M, Ansorge S, Brocke S.

Int Immunopharmacol. 2006 Dec 20;6(13-14):1935-42. Epub 2006 Aug 17.

PMID:
17161346
23.

Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease.

Bank U, Heimburg A, Helmuth M, Stefin S, Lendeckel U, Reinhold D, Faust J, Fuchs P, Sens B, Neubert K, Täger M, Ansorge S.

Int Immunopharmacol. 2006 Dec 20;6(13-14):1925-34. Epub 2006 Oct 17.

PMID:
17161345
24.

Effect of L-arginine on asymmetric dimethylarginine (ADMA) or homocysteine-accelerated endothelial cell aging.

Scalera F, Martens-Lobenhoffer J, Täger M, Bukowska A, Lendeckel U, Bode-Böger SM.

Biochem Biophys Res Commun. 2006 Jul 7;345(3):1075-82. Epub 2006 May 11.

PMID:
16713997
25.

Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.

Biton A, Bank U, Täger M, Ansorge S, Reinhold D, Lendeckel U, Brocke S.

Adv Exp Med Biol. 2006;575:177-86. No abstract available.

PMID:
16700521
26.

Dipeptidylpeptidase IV (DPIV) and alanyl-aminopeptidases (AAPs) as a new target complex for treatment of autoimmune and inflammatory diseases-proof of concept in a mouse model of colitis.

Bank U, Tadje J, Helmuth M, Stefin S, Täger M, Wolke C, Wischeropp A, Ittenson A, Reinhold D, Ansorge S, Lendeckel U.

Adv Exp Med Biol. 2006;575:143-53. No abstract available.

PMID:
16700517
27.

Rapid pacing of embryoid bodies impairs mitochondrial ATP synthesis by a calcium-dependent mechanism--a model of in vitro differentiated cardiomyocytes to study molecular effects of tachycardia.

Schild L, Bukowska A, Gardemann A, Polczyk P, Keilhoff G, Täger M, Dudley SC, Klein HU, Goette A, Lendeckel U.

Biochim Biophys Acta. 2006 Jun;1762(6):608-15. Epub 2006 Apr 19.

28.

Assigning the phenotype of a natural regulatory T-cell to the human T-cell line, KARPAS-299.

Wolke C, Tadje J, Bukowska A, Täger M, Bank U, Ittenson A, Ansorge S, Lendeckel U.

Int J Mol Med. 2006 Feb;17(2):275-8.

PMID:
16391826
29.

Aspirin reduces endothelial cell senescence.

Bode-Böger SM, Martens-Lobenhoffer J, Täger M, Schröder H, Scalera F.

Biochem Biophys Res Commun. 2005 Sep 9;334(4):1226-32.

PMID:
16039999
30.

Erythropoietin increases asymmetric dimethylarginine in endothelial cells: role of dimethylarginine dimethylaminohydrolase.

Scalera F, Kielstein JT, Martens-Lobenhoffer J, Postel SC, Täger M, Bode-Böger SM.

J Am Soc Nephrol. 2005 Apr;16(4):892-8. Epub 2005 Feb 23.

31.

Expression of opioid receptor subtypes and their ligands in fibrillating human atria.

Lendeckel U, Müller C, Röcken C, Laube B, Täger M, Huth C, Klein HU, Goette A.

Pacing Clin Electrophysiol. 2005 Jan;28 Suppl 1:S275-9.

PMID:
15683515
32.

Endogenous nitric oxide synthesis inhibitor asymmetric dimethyl L-arginine accelerates endothelial cell senescence.

Scalera F, Borlak J, Beckmann B, Martens-Lobenhoffer J, Thum T, Täger M, Bode-Böger SM.

Arterioscler Thromb Vasc Biol. 2004 Oct;24(10):1816-22. Epub 2004 Aug 12.

PMID:
15308550
33.

[Infections caused by Varicella Zoster virus in children with cancer aged less than 15 years old].

Folatre I, Zolezzi P, Schmidt D, Marín F, Täger M.

Rev Med Chil. 2003 Jul;131(7):759-64. Spanish.

PMID:
14513696
34.

Thiol-inducing and immunoregulatory effects of flavonoids in peripheral blood mononuclear cells from patients with end-stage diabetic nephropathy.

Dietzmann J, Thiel U, Ansorge S, Neumann KH, Täger M.

Free Radic Biol Med. 2002 Nov 15;33(10):1347-54.

PMID:
12419466
35.

[Seroprevalence of antibodies against hantavirus in 10 communities of the IX Region of Chile where hantavirus infection were diagnosed].

Castillo C, Sanhueza L, Täger M, Muñoz S, Ossa G, Vial P.

Rev Med Chil. 2002 Mar;130(3):251-8. Spanish.

PMID:
12043366
36.

Extracellular cysteines define ectopeptidase (APN, CD13) expression and function.

Firla B, Arndt M, Frank K, Thiel U, Ansorge S, Täger M, Lendeckel U.

Free Radic Biol Med. 2002 Apr 1;32(7):584-95.

PMID:
11909693
37.

Antioxidant and antiprotease status in peripheral blood and BAL fluid after cardiopulmonary bypass.

Frass OM, Bühling F, Täger M, Frass H, Ansorge S, Huth C, Welte T.

Chest. 2001 Nov;120(5):1599-608.

PMID:
11713141
38.

Restoration of the cellular thiol status of peritoneal macrophages from CAPD patients by the flavonoids silibinin and silymarin.

Täger M, Dietzmann J, Thiel U, Hinrich Neumann K, Ansorge S.

Free Radic Res. 2001 Feb;34(2):137-51.

PMID:
11264891
39.

Evidence of a defective thiol status of alveolar macrophages from COPD patients and smokers. Chronic obstructive pulmonary disease.

Täger M, Piecyk A, Köhnlein T, Thiel U, Ansorge S, Welte T.

Free Radic Biol Med. 2000 Dec;29(11):1160-5.

PMID:
11121724
41.
42.

Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) induces secretion of transforming growth factor-beta 1 (TGF-beta 1) in stimulated mouse splenocytes and thymocytes.

Reinhold D, Bank U, Bühling F, Täger M, Born I, Faust J, Neubert K, Ansorge S.

Immunol Lett. 1997 Jun;58(1):29-35.

PMID:
9436466
43.

Painful proximal diabetic neuropathy: inflammatory nerve lesions and spontaneous favorable outcome.

Said G, Elgrably F, Lacroix C, Planté V, Talamon C, Adams D, Tager M, Slama G.

Ann Neurol. 1997 Jun;41(6):762-70.

PMID:
9189037
44.

The effect of anti-CD26 antibodies on DNA synthesis and cytokine production (IL-2, IL-10 and IFN-gamma) depends on enzymatic activity of DP IV/CD26.

Reinhold D, Kähne T, Täger M, Lendeckel U, Bühling F, Bank U, Wrenger S, Faust J, Neubert K, Ansorge S.

Adv Exp Med Biol. 1997;421:149-55. Review. No abstract available.

PMID:
9330691
45.

CD26/dipeptidyl peptidase IV in lymphocyte growth regulation.

Ansorge S, Bühling F, Kähne T, Lendeckel U, Reinhold D, Täger M, Wrenger S.

Adv Exp Med Biol. 1997;421:127-40. Review.

PMID:
9330689
46.

Overproduction of IL-7, IL-10 and TGF-beta 1 in multiple myeloma.

Kröning H, Täger M, Thiel U, Ittenson A, Reinhold D, Bühling F, Kettner E, Ansorge S.

Acta Haematol. 1997;98(2):116-8. No abstract available.

47.

gamma-Glutamyl transpeptidase-cellular expression in populations of normal human mononuclear cells and patients suffering from leukemias.

Täger M, Ittenson A, Franke A, Frey A, Gassen HG, Ansorge S.

Ann Hematol. 1995 May;70(5):237-42.

PMID:
7599285
48.

[Hydatidosis in the IXth Region of Chile. A regional problem and challenge].

Gutiérrez R, Inostroza J, Oberg C, Baquerizo A, Muñoz W, Eskuche W, Fierro J, Pineda V, Täger M.

Rev Med Chil. 1992 Mar;120(3):311-6. Review. Spanish.

PMID:
1342486
49.

The art of health promotion.

Tager MJ.

Am J Health Promot. 1990 Sep-Oct;5(1):14-5. doi: 10.4278/0890-1171-5.1.14. No abstract available.

PMID:
22188145
50.

Cross-cultural training for health promotion.

Tager MJ.

Am J Health Promot. 1990 Jul;4(6):474-5. doi: 10.4278/0890-1171-4.6.474. No abstract available.

PMID:
22204626

Supplemental Content

Support Center